Copyright: ©Author(s) 2026.
World J Gastroenterol. Jul 28, 2026; 32(28): 121267
Published online Jul 28, 2026. doi: 10.3748/wjg.121267
Published online Jul 28, 2026. doi: 10.3748/wjg.121267
Table 1 Baseline characteristics of the study participants, mean ± SD/n (%)
| Characteristics | Control | Adenoma | CRC | P value |
| Age (years) | 49.68 ± 11.67 | 50.15 ± 10.49 | 54.93 ± 8.45 | 0.022 |
| Female | 24 (20) | 22 (18.3) | 19 (15.8) | 0.528 |
| Body height (cm) | 165.75 ± 6.93 | 167.85 ± 7.08 | 168.25 ± 8.92 | 0.463 |
| Body weight (kg) | 64.86 ± 10.48 | 69.05 ± 14.08 | 72.22 ± 14.55 | 0.09 |
| Body mass index (kg/m2) | 23.53 ± 3.06 | 24.36 ± 3.77 | 25.4 ± 4.09 | 0.099 |
| Hypertension | 11 (9.2) | 12 (10) | 13 (10.8) | 0.888 |
| Diabetes | 3 (2.5) | 3 (2.5) | 4 (3.3) | 0.897 |
| Use of antithrombotic agents | 2 (1.7) | 1 (0.8) | 1 (0.8) | 0.772 |
| Current smoking | 9 (7.5) | 8 (6.7) | 9 (7.5) | 0.952 |
| Current drinking | 5 (4.2) | 14 (11.7) | 19 (15.8) | 0.003 |
- Citation: Jing W, Qin L, Zhang XH, Pan F, Ren RR, Li Y, Zhang Y, Peng LH, Wang ZK, Zhang XL. Diagnostic efficacy of fecal calprotectin combined with a high-sensitivity quantitative fecal immunochemical test for colorectal tumors. World J Gastroenterol 2026; 32(28): 121267
- URL: https://www.wjgnet.com/1007-9327/full/v32/i28/121267.htm
- DOI: https://dx.doi.org/10.3748/wjg.121267